Immune Checkpoint Inhibitors and Cancer Vaccines Flashcards

1
Q

What is meant by immune surveillance in relation to cancer?

A

Immune system has evolved to constantly survery tissues for malignant transformation and target these cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the relationship between immune regulation and cancer?

A

Immunocompromised have higher rates of cancer - unable to surveil for changes
Over active - inc inflammation inc risk of cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What immune system part is considered to be cancer killing?

A

NK cells
CD8+ cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the key response shown by the immune system against cancer shown by lymphocytes?

A

Antibodies against tumour antigens
T cells with TCR against tumour specific peptides
Lymphocytes infiltrate into solic tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the role of NK cells against cancerous cells?

A

Regulated by inhibitory and activatory receptor on surface that respond to antigen on cell surface
When activated -> cytotoxicity and cytokine production causes target cell death.
Innate immune system response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What changes in cancer cells make them more vulnerable to death by NK cells?

A

Loss of HLA class 1 -> norm acts as inhibitor ligand = loss of inhibitory signalling through NKG2A-CD94

Upregulation of stress ligands (MICA) = activatory signalling through NKG2D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the three signals required to activate naive immune cells?

A
  1. Antigen receptor signal - TCR on T cell to MHC bound peptide on APC
  2. Co-stimulation - CD28 on T cell with B7 (CD80 and CD86) on APC
  3. Polarising cytokine signals - released by APC to determinete type of effector response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the role of the different type of T cells in launching a response against cancer?

A

CD4+ - help prime CD8 T cell response and formation for CD8 memory

CD8+ - killing cancer cells, granzyme, perofin and death ligands.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Define tumour associated antigens?

A

Antigens unusually highly expressed on cancer cells compared to normal cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Define tumour specific antigens

A

Only found on cancer cells (neoantigens) result of somatic mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What antigens are commonly associated with cancer?

A

Cancer testis antigens - previously found in testes, immune system previously ignorant
Viral antigens - HPV early proteins, virus was oncogenic trigger

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why is the tumour peptidome important to cancer immunosurveillance?

A

Is what proteins the tumour produces
Changes across time within an individual and can be different between individuals with same cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How to cancer cell evade detection from the immune system?

A

Develop due to selective pressure:
1. Not present immunogenic self-altered peptide
2. Downregulate HLA-1 to avoid CD8+ activation
3. Express surface and secreted molecules to inhibitor effector cells of immune system
4. Create a microenvironment that favours immunological tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the tumour microenvironment?

A

Highly heterogeneity
‘Ecosystem’ of tumour and surrounding immune cells, stroma and blood vessels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What immune components are typically found in the tumour microenvironment?

A

Cytotoxic T cells
Helper T cells
Regulatory T cells
Macrophages
Myeloid derived suppressor cells
Cytokine milieu -> what and proportion of cytokines present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What affects how immunogenic a tumour is?

A

Low or high number of mutations
Number of tumour infiltrating lymphocytes
Proportion of immune subsets (Th1 v reg, M1 v M2, NK etc)

17
Q

What is the basic principle of the aim of immunotherapy against cancer?

A

Primar the activation of naive T cells against tumour specific antigens
Damplen the immunoregulatory mechanism of cancer cells
Shift the balance towards immune activation and tumour cancer killing

18
Q

What is the general concern with immunotherapy?

A

Turn of immunoregulatory mechanism
Leads to increased response to self antigens, high levels of inflammation and damage to host tossues.

19
Q

What is the role of Rituximab against cancer? (basic)

A

Targets CD20
Treatment for non-Hodgkin lymphoma

20
Q

What is the role of rituximab against cancer?

A

Targets CD20 on B cells
Treatment for non-Hodgkins lymphoma

Triggers antibody dependent cell mediated cytotoxicity by NK and macro
Classical complement pathway activation
Formation of membrane attack complex.

21
Q

What is the role of Trastuzumab (herceptin) in the treatment of cancer?

A

Targets HER2
Treatment of HER2-positive breast cancer
Blocks dimerisation and signalling - inhibits receptor signalling hence cell proliferation

22
Q

What are immune checkpoint inhibitor drugs?

A

Monoclonal antibodies given IV - typically in combination with others.
Block antibodies that bind receptor or block receptor itself in immune checkpoint pathway -> inhibits inhibition of immune system.
Remove brakes on immune system.

23
Q

What is important in practice for the use of Immune checkpoint inhibitor drugs against cancer?

A

Expensive
Typically used in combination with other drugs
Given IV
Used in advanced cancer - consider refractory or relapsed
Cause immune-related adverse events at high frequency (includes vitiligo, GI bleeding, pneumonitits)

24
Q

What is the purpose of ipilimumab in cancer treatment?

A

Block CTLA-4
Used in comb with PD-1 inhibitor for advanced melanoma
CTLA-4 is found on surface of T cells, is bound to be signals on T reg and APC to turn off immune cell function

25
Q

What is the purpose of nivolumab and pembrolizumab in cancer treatment?

A

Block PD-1 (receptor)
NSCLC with PD-L1 >50% tumour proportion
PD-1 found on surface of immune cells, ligand turn off immune cells

26
Q

What is the purpose of atezolizumab, avelumab, duravalumab?

A

Block PD-L1
Atezolizumab is used to treat advanced urethelial carcinoma
PD-1 found on surface of immune cells, ligand (can be found on surface of cancer cells) turn off the cancer cells

27
Q

What is the role of CTLa-4 in the immune system?

A

Found in secondary lymphoid organs on Tregs and activated T cells
Imhibits priming of immune cells (CD4>CD8)
Is a competitieve inhibitor of CD28 co-stimulation -> binds to B7 with high affinity
Norm = prevents autoimmune response to self-antigen, trig function Treg, prevents uncontrolled expansion of activated T cells or activation of naive T cells

28
Q

How can resistance to immune checkpoint inhibitor therapy arise?

A

Inc immune response against tumour
Acts as a selective pressure
Results in cancer mutation for immune evasion leading to loss of response
Risk can be reduced by using combination treatments

29
Q

What is a key side effect os a strong response to ipilimumab?

30
Q

What is the role of PD-1 in the immune system?

A

Expressed by activated T cells in peripheral tissues
Targets effector phase of immune response (CD8>CD4)
Ligand L1 and L2 express by host tissue
Chronic exposure to any antigen leads to inc expression of PD-1 by T cells (exhausted)
Signalling of Pd-1 decreases T cell proliferation, cytokine secretion and cytotoxic activity = anergic

31
Q

What is important to know about checkpoint inhibitor therapy side effects?

A

Immune related adverse events - due to loss of normal tolerance mechanisms
More common with CTLA-4 than PD1
More common with combination therapy than signular
Can persist after treatment ends
Common = dermatitis and colitis

32
Q

What are some common viruses associated with their respective cancers?

A

EBV, HBV, HCV HIV and HPV

Kaposi sarcoma in AIDs
Hodkgins and EBV
Liver and HBV > HCV

33
Q

How does HPV lead to cervical cancer?

A

HOV 16 and 18 = main cancer causing
Viral protein E6 -> promotes degradation of p53
E7 binds and inactivates Rb
Suppress apoprotosis, allow DNA damage and progression through cell cycle

34
Q

What HPV vaccination programme exists?

A

2008 - 12/13yrs females UK
2019 - 12/13yrs males UK
2012 changed from cervarix to gardasil vaccine

35
Q

What is the Imlygic (T-VEC) vaccination for cancer?

A

Genetically modified oncolytic virus derviedfrom HSV-1
Targets metastatic melanoma (Not visceral organs)
Injected into lesion every 2-3 weeks
Infects tumour cells - secretes GM-CSF to recruit and activate APC
Also cause direct lysis of tumour cells

36
Q

What can be done to improve the efficacy/safety of immune checkpoint inhibitor therapy in cancer?

A

New targets - TIM2, LAG3 and TIGIT
Not use in children - concern over organ damage and long term comp
Combine with personalised tumour antigen specific vaccine
Pre radio/chemo to inc chance of response (only 25% currently respond)